射频导管消融术与冷冻球囊消融术治疗心房颤动的长期随访结果比较

Radiofrequency catheter ablation versus cryoballoon ablation for atrial fibrillation in long-term follow up results

  • 摘要:
    目的 比较射频导管消融术(RFCA)与冷冻球囊消融术(CBA)治疗心房颤动(简称房颤)的长期有效性。
    方法 选取124例房颤患者为研究对象,根据治疗方式的不同分为射频组55例和冷冻组69例。比较2组患者长期随访的房颤复发情况、长期有效性。
    结果 研究过程中,共有11例患者术后失访,其中射频组失访7例,冷冻组失访4例。术后随访过程中,射频组有26例(54.17%)房颤复发,冷冻组有35例(53.85%)房颤复发, 2组房颤复发率的差异无统计学意义(P>0.05)。射频组与冷冻组阵发性房颤(ParAF)复发例数分别为21例与28例,持续性房颤(PerAF)复发例数分别为5例与7例,差异均无统计学意义(P>0.05)。2组生存曲线差异无统计学意义(P>0.05)。
    结论 RFCA与CBA治疗房颤患者的长期有效性无显著差异, PerAF患者的复发率高于ParAF患者,长期复发率仍有待进一步降低。

     

    Abstract:
    Objective To compare the long-term efficacy of radiofrequency catheter ablation (RFCA) and cryoballoon ablation (CBA) in the treatment of patients with atrial fibrillation.
    Methods A total of 124 patients with atrial fibrillation were selected, and were divided into radiofrequency group (n=55) and cryotherapy group (n=69) according to different treatments. Recurrence of atrial fibrillation and long-term efficacy during long-term follow-up were compared between the two groups.
    Results During the study, 11 patients were lost in postoperative follow up, including 7 cases in the radiofrequency group and 4 cases in the cryotherapy group. During the postoperative follow-up, 26 patients (54.17%) in the radiofrequency group and 35 patients (53.85%) in the cryotherapy group had recurrence of atrial fibrillation, and there was no significant difference in the recurrence of atrial fibrillation between the two groups (P>0.05). The number of recurrent cases with paroxysmal atrial fibrillation (ParAF) were 21 and 28 respectively in the radiofrequency group and the cryotherapy group, the number of recurrent cases with persistent atrial fibrillation (PerAF) were 5 and 7 respectively, and there were no significant differences between two groups (P>0.05). There was no significant difference in survival curve between the two groups (P>0.05).
    Conclusion There is no significant difference in the long-term efficacy between RFCA and CBA in the treatment of patients with atrial fibrillation. The recurrence rate of patients with PerAF is higher than that of patients with ParAF, and the long-term recurrence rate needs to be further reduced.

     

/

返回文章
返回